drugset / Trial / NCT02137746
Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety of the second cycle of DCVAC/PCa in patients who completed the first cycle of DCVAC/PCa in the clinical trial SP003 without an objective progression of the disease.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-04
- Completion
- 2017-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STAPULDENCEL | Vaccine | — | — |